Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Chu, Van Trung Dr. (2) Graf, Robin Dr. (2) Kammertöns, Thomas Dr. (6) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Kühn, Ralf Dr. (19) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (3) Willimsky, Gerald Dr. (5) (-) Blankenstein, Thomas Prof. Dr. (24) (-) Uckert, Wolfgang Prof. Dr. (6) Bioinformatik der Genregulation (1) Experimentelle Ultrahochfeld-MR (6) Genetik metabolischer und reproduktiver Störungen (1) (-) Genom-Editierung & Krankheitsmodelle (1) Genomics (1) Immunregulation und Krebs (1) Magnetic Resonance (6) Mobile DNA (2) (-) Molekulare Immunologie und Gentherapie (25) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (1) Zelluläre Neurowissenschaften (3) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) (-) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (6) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) (-) 2013 (11) 2014 (3) 2015 (3) (-) 2016 (6) 2017 (6) 2018 (6) 2019 (9) 2020 (1) 2021 (5) 2022 (7) 2023 (5) 2024 (2) 26 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Uckert, Wolfgang Prof. Dr.Genom-Editierung & KrankheitsmodelleMolekulare Immunologie und Gentherapie 200320132016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein 01. November 2016 / Proc Natl Acad Sci U S A Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line V.T. Chu R. Graf T. Wirtz T. Weber J. Favret X. Li K. Petsch N.T. Tran M.H. Sieweke C. Berek R. Kühn K. Rajewsky 15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. November 2013 / Nat Med High-throughput identification of antigen-specific TCRs by TCR gene capture C. Linnemann B. Heemskerk P. Kvistborg R.J.C. Kluin D.A. Bolotin X. Chen K. Bresser M. Nieuwland R. Schotte S. Michels R. Gomez-Eerland L. Jahn P. Hombrink N. Legrand C.J. Shu I.Z. Mamedov A. Velds C.U. Blank J.B.A.G. Haanen M.A. Turchaninova R.M. Kerkhoven H. Spits S.R. Hadrup M.H.M. Heemskerk T. Blankenstein D.M. Chudakov G.M. Bendle T.N.M. Schumacher 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 07. April 2016 / Nat Biotechnol Receptor combinations hone T-cell therapy T. Blankenstein 17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
01. November 2016 / Proc Natl Acad Sci U S A Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line V.T. Chu R. Graf T. Wirtz T. Weber J. Favret X. Li K. Petsch N.T. Tran M.H. Sieweke C. Berek R. Kühn K. Rajewsky
15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. November 2013 / Nat Med High-throughput identification of antigen-specific TCRs by TCR gene capture C. Linnemann B. Heemskerk P. Kvistborg R.J.C. Kluin D.A. Bolotin X. Chen K. Bresser M. Nieuwland R. Schotte S. Michels R. Gomez-Eerland L. Jahn P. Hombrink N. Legrand C.J. Shu I.Z. Mamedov A. Velds C.U. Blank J.B.A.G. Haanen M.A. Turchaninova R.M. Kerkhoven H. Spits S.R. Hadrup M.H.M. Heemskerk T. Blankenstein D.M. Chudakov G.M. Bendle T.N.M. Schumacher
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau